Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
[Of worms and men--Administration of helminth products as an innovative approach to treatment of autoimmune diseases].
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
[Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)].
Functional plasticity of the visual system in multiple sclerosis.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.
PDE4B as a microglia target to reduce neuroinflammation.
New Clues to Link Between MS Drug Tysabri and Rare Brain Disease
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Temporal reorganization to overcome monocular demyelination.
Development of the Cell Population in the Brain White Matter of Young Children.
Effects of fingolimod in relapsing-remitting multiple sclerosis.
Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis.
Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis.
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Unilateral optic neuritis, scleritis and exudative retinal detachment due to recurrent orbital pseudotumor.
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases.
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
Pages
« first
‹ previous
…
288
289
290
291
292
293
294
295
296
…
next ›
last »